Randomized control trial to assess the efficacy and safety of NRL/2019/5PNW with micronutrient fortification to promote health and well being in woman in fertile age - Nil

etsurf Communications Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Fertile Women Aged 18 - 50 years
•BMI in the range of 20-26 Kg/m2 should be incorporated
•Subjects having good physical condition and sound mental status.
•In the judgment of the Principal Investigator, able to comply with protocol requirements.
•Subjects willing to sign written informed consent
•Willing to abstain from use of additional vitamin or mineral supplements, nutritional supplements and or medical foods if applicable.

•Allergies to ingredients in product/ milk
•Subjects with uncontrolled and uncomplicated diabetes (HbA1C NMT 7.0 % and blood pressure
•NMT 140/90 mm hg) may or may not be on prescription.
•Presence of any major illness such as cancer, heart disease, COPD, Asthma etc.
•Subjects with medical history of any major illness such as cancer, heart disease, COPD, Asthma etc. in the past
•Subjects with history of any acute or chronic illness that may affect the patientâ??s participation in the study
•Use of prescription medications and/or nonprescription medications for weight loss.
•Subjects with acute illness or history of major or minor surgery in the past one year.
•Female subjects who are currently pregnant and/or breast feeding
•Subjects not willing to participate in study.
•Subjects with history of hysterectomy, IUI and IVF
•Subjects with PCOS and or on any hormone replacement therapy
•Subjects on oral hormonal contraceptive

发起方

etsurf Communications Pvt Ltd